Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1618
    -0.0065 (-0.56%)
     
  • GBP/USD

    1.2379
    -0.0059 (-0.47%)
     
  • Bitcoin GBP

    52,080.62
    +1,460.40 (+2.89%)
     
  • CMC Crypto 200

    1,334.09
    +21.47 (+1.58%)
     
  • S&P 500

    4,978.77
    -32.35 (-0.65%)
     
  • DOW

    37,965.54
    +190.16 (+0.50%)
     
  • CRUDE OIL

    83.34
    +0.61 (+0.74%)
     
  • GOLD FUTURES

    2,408.80
    +10.80 (+0.45%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring

3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring

Shares of Rigel Pharmaceuticals (NASDAQ: RIGL) recently popped after the company announced a collaboration deal with one of America's largest drugmakers, Eli Lilly (NYSE: LLY). A new collaboration deal with a big pharmaceutical company isn't the only reason to keep an eye on this often overlooked biotech stock. Here's why investors can look forward to outstanding returns from Rigel Pharmaceuticals in the years to come.